Failure of Thrombus to Resolve in Urokinase-Type Plasminogen Activator Gene-Knockout Mice: Rescue by Normal Bone Marrow-Derived Cells

Background—Monocytes may have an important role in the resolution of venous thrombosis. Increased expression of tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA) is associated with an ingress of monocytes into the thrombus. This study was designed to evaluate the importance of these activators in thrombus resolution. Methods and Results—Inferior caval vein thrombosis was induced in cohorts of adult wild-type, uPA gene-knockout (uPA−/−), and tPA gene-knockout (tPA−/−) mice in a flow model. Thrombi were harvested from wild-type and uPA−/− mice (n=60 per group) between 1 and 60 days. Thrombi were also obtained from groups of wild-type and tPA−/− mice (n=24 per group) between 1 and 28 days. Thrombus size and macrophage content were measured by computer-assisted image analysis. Thrombus resolution was significantly impaired in the uPA−/− mice compared with wild-type controls (P <0.0001) but was unaffected in tPA−/− mice. Monocyte content in wild-type mice was highest at 14 days after thrombus induction and was ≈4 times greater than in uPA−/− mice (P =0.0043). Thrombus size in uPA−/− mice transplanted with wild-type marrow (0.29±0.06 mm2) was significantly smaller than in uPA−/− mice given uPA−/− bone marrow (3.9±1.1 mm2) (P =0.0022). Donor bone marrow–derived cells expressing LacZ were present in the thrombus after transplantation. Conclusions—The resolution of experimental venous thrombus is dependent on uPA but is unaffected by the absence of tPA. Absence of uPA is also associated with delayed monocyte recruitment into the thrombus. Transplanting wild-type bone marrow restores thrombus resolution in uPA−/− animals, suggesting an important role for bone marrow–derived cells in this process.

[1]  L. Bobrow,et al.  The tissue plasminogen activator and urokinase response in vivo during natural resolution of venous thrombus. , 1995, Journal of vascular surgery.

[2]  S. Rafii,et al.  Efficient mobilization and recruitment of marrow-derived endothelial and hematopoietic stem cells by adenoviral vectors expressing angiogenic factors , 2002, Gene Therapy.

[3]  H. Steenfos,et al.  Growth factors and wound healing. , 1994, Scandinavian journal of plastic and reconstructive surgery and hand surgery.

[4]  A. Luttun,et al.  Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure , 1999, Nature Medicine.

[5]  L. Happerfield,et al.  TISSUE PLASMINOGEN ACTIVATOR PRODUCTION BY MONOCYTES IN VENOUS THROMBOLYSIS , 1996, The Journal of pathology.

[6]  S. Shapiro,et al.  Contribution of Monocytes/Macrophages to Compensatory Neovascularization: The Drilling of Metalloelastase-Positive Tunnels in Ischemic Myocardium , 2000, Circulation research.

[7]  D. Wiseman,et al.  Macrophages, wound repair and angiogenesis. , 1988, Progress in clinical and biological research.

[8]  M. Waltham,et al.  Recruitment of Labelled Monocytes by Experimental Venous Thrombi , 2001, Thrombosis and Haemostasis.

[9]  P. D’Amore,et al.  Growth Factors and Angiogenesis in Wound Healing , 1997 .

[10]  K. Burnand,et al.  A model of in vivo human venous thrombosis that confirms changes in the release of specific soluble cell adhesion molecules in experimental venous thrombogenesis. , 1999, Journal of vascular surgery.

[11]  J. Isner,et al.  Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. , 1999, Circulation research.

[12]  P. Carmeliet,et al.  Tissue plasminogen activator (tPA) deficiency exacerbates cerebrovascular fibrin deposition and brain injury in a murine stroke model: studies in tPA-deficient mice and wild-type mice on a matched genetic background. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[13]  M. Cuzner,et al.  Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system , 1999, Journal of Neuroimmunology.

[14]  D. E. Strandness,et al.  Deep venous insufficiency: the relationship between lysis and subsequent reflux. , 1993, Journal of vascular surgery.

[15]  K. Alitalo,et al.  Endothelial cells genetically selected from differentiating mouse embryonic stem cells incorporate at sites of neovascularization in vivo. , 2002, Journal of cell science.

[16]  S. Rafii,et al.  Evidence for circulating bone marrow-derived endothelial cells. , 1998, Blood.

[17]  F. Blasi.  Proteolysis, Cell Adhesion, Chemotaxis, and Invasiveness Are Regulated by the u-PA-u-PAR-PAI-1 System , 1999, Thrombosis and Haemostasis.

[18]  M. Waltham,et al.  Monocyte chemotactic protein-1 (MCP-1) accelerates the organization and resolution of venous thrombi. , 1999, Journal of vascular surgery.

[19]  S. Haas.  Deep vein thrombosis: beyond the operating table. , 2000, Orthopedics.

[20]  S. Sevitt,et al.  The mechanisms of canalisation in deep vein thrombosis , 1973, The Journal of pathology.

[21]  V. V. van Hinsbergh,et al.  Role of fibrin and plasminogen activators in repair-associated angiogenesis: in vitro studies with human endothelial cells. , 1997, EXS.

[22]  H. Movat,et al.  The in vivo quantitation and kinetics of monocyte migration into acute inflammatory tissue. , 1981, The American journal of pathology.

[23]  J. Humphries,et al.  The role of the monocyte in the generation and dissolution of arterial and venous thrombi. , 1998, Cardiovascular surgery.

[24]  M. Olman,et al.  Modulating the fibrinolytic system of peripheral blood mononuclear cells with adenovirus. , 2001, Human gene therapy.

[25]  P. Carmeliet,et al.  Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[26]  M. Linton,et al.  Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Hillebrands,et al.  Bone marrow does not contribute substantially to endothelial-cell replacement in transplant arteriosclerosis , 2002, Nature Medicine.

[28]  A. Forster,et al.  Thrombolysis in Deep Vein Thrombosis: Is there still an Indication? , 2001, Thrombosis and Haemostasis.

[29]  J. Homans.  Diseases of the veins. , 1946, The New England journal of medicine.

[30]  P. Carmeliet,et al.  Physiological consequences of loss of plasminogen activator gene function in mice , 1994, Nature.

[31]  Alberto Smith,et al.  Antithrombotic effects of controlled inhibition of factor VIII with a partially inhibitory human monoclonal antibody in a murine vena cava thrombosis model. , 2002, Blood.

[32]  J. Loscalzo,et al.  Fibrin(ogen) is internalized and degraded by activated human monocytoid cells via Mac-1 (CD11b/CD18): a nonplasmin fibrinolytic pathway. , 1993, Blood.

[33]  H. Lijnen.  Elements of the Fibrinolytic System , 2001, Annals of the New York Academy of Sciences.

[34]  P. Carmeliet,et al.  Plasminogen deficiency differentially affects recruitment of inflammatory cell populations in mice. , 1998, Blood.